Cargando…
Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery
BACKGROUND: Systemic immune–inflammation index (SII), calculated by immunoinflammatory cell counts of peripheral blood, is considered a predictor of survival outcome in several solid tumors, including gastric cancer (GC). However, there is no study focusing on the prognostic value of SII in the earl...
Autores principales: | He, Kang, Si, Lixiang, Pan, Xiaohua, Sun, Ling, Wang, Yajing, Lu, Jianwei, Wang, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918673/ https://www.ncbi.nlm.nih.gov/pubmed/35296020 http://dx.doi.org/10.3389/fonc.2022.829689 |
Ejemplares similares
-
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
por: Huang, Yihong, et al.
Publicado: (2021) -
Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Zhou, Yuting, et al.
Publicado: (2022) -
Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
por: Zhu, Ziyu, et al.
Publicado: (2020) -
Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery
por: Xie, Jianwei, et al.
Publicado: (2021) -
Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy
por: Chen, Qing, et al.
Publicado: (2023)